1361/2088US=84-A / Biol/Mol
Lee C, Shah A, Liu VC, Park II, Wong LY, Huang X, Huang L, Zhou VW, Medler T, Kundu SD, Zhang Q, Smith ND. Transformig growth factor-B in developing and advanced cancers: adoptive transfer of tumor reactive TGF-B insensitive CD8 T cellss for cancer therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 443-61. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TUMOR DERIVADO DE TGF-B; VIGILANCIA IMUNE; TGF-B; TGF-B INSENSIVEIS CD8 + CELULAS-T; A TRANSFERENCIA ADOPTIVA DE CELULAS CD8 + CELULAS-T; ERRADICACAO DO TUMOR


1362/2088US=84-A / Biol/Mol
Dennler S, Mawviel A, Verrecchia F. Transformig growth factor-B in developing and advanced cancers: TGF-B and stromal influences over local tumor invasion. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 537-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

SMAD; TGF-B; ECM REMODELACAO; MIOFIBROBLASTOS; DESMOPLASIA


1363/2088US=84-A / Biol/Mol
Datta PK, Mann JR. Development of inhibitors of transforming growth factor-B signaling for therapy: transforming growth factor-B (TGF-B) signaling inhibitors in cancer therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 573-87. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; PEQUENA MOLECULA INIBIDORES; TRANSDUCAO DE SINAL; SUPRESSOR DE TUMOR; PROMOTOR DE TUMOR; BIOMARCADOR; TERAPIA DO CANCER


1364/2088US=84-A / Biol/Mol
Schlingensiepen KH, Jachimczak P, Fischer-Blass B, Fischer D, Specht H, schmaus S, Schlingensiepen R. Development of inhibitors of transforming growth factor-B signaling for therapy: targeted downregulation of TGF-B2 with AP 12009 in tumor therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 635-51. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

OLIGODEOXINUCLEOTIDOS ANTISENSE; CANCER; GLIOMA MALIGNO; TGF-B; USO TERAPEUTICO


1365/2088US=86 / Biol/Mol
Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R. Apoptotic pathways in tumor progression and therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 47-79. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8.

VIAS APOPTOTICAS; PROGRESSAO TUMORAL; TERAPIA DE CANCER; APOPTOSE; INIBIDORES; TRANSDUCAO DE SINAL; ONCOGENE; MAQUINARIA APOPTOTICA; DROGAS QUIMIOTERAPICAS; RESISTENCIA A DROGA


1366/2088US=86 / Biol/Mol
Bialik S, Kimchi A. Autophagy and tumor suppression: recent advances in understanding the link between autophagic cell death pathways and tumor development. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 177-200. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8.

AUTOFAGIA; SUPRESSAO DO TUMOR; AUTOFAGICOS; VIAS DE MORTE CELULAR; DESENVOLVIMENTO DE TUMORES; MORTE CELULAR PROGRAMADA; DAPK; BECLIN 1; MTOR


1367/2088US=86 / Biol/Mol
Dykxhoorn DM, Chowdhury D, Lieberman J. RNA interference and cancer: endogenous pathways and therapeutic approaches. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 299-329. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8.

RNA DE INTERFERENCIA; CANCER; VIAS ENDOGENAS; MICRORNA; MICROARRAY; PERFIL DO TUMOR; SIRNA; PROGNOSTICO; TERAPIA


1368/2088US=438 / Tese/FAP
Crespo RB. Análise da expressão proteica de marcadores da via Wnt em carcinoma de vulva HPV positivo e negativo. [Protein expression analysis of markers from WNT pathway in HPV positive and negative vulvar carcinomas]. São Paulo, 2012. 97 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/RodrigoCrespo/RodrigoCrespo.pdf

Curriculum Lattes

NEOPLASIAS VULVARES; DOENCAS DOS GENITAIS FEMININOS; PROTEIAS WNT; CARCINOMA DE CELULAS ESCAMOSAS; PAPILOMAVIRUS HUMANO 16; PAPILOMAVIRUS HUMANO 18


1369/2088US=440 / Tese/FAP
Sousa EA. Linfangiogênese em carcinoma epidermóide oral e associação com características clinicopatológicas. [Lymphangiogenesis in oral squamous cell carcinoma and association with clinicopathological characteristics]. São Paulo, 2012. 72 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/ElenAlvesSousa/ElenAlvesSousa.pdf

Curriculum Lattes

LINFANGIOGENESE; CARCINOMA DE CELULAS ESCAMOSAS; CAVIDADE ORAL; NEOPLASIAS DE CABECA E PESCOCO; IMUNOISTOQUIMICA; MARCADORES BIOLOGICOS DE TUMOR


1370/2088US=441 / Tese/FAP
Cestari FMS. Avaliação do valor da expressão imunoistoquímica da e-caderina e metaloproteases da matriz extracelular tipos 2 e 9 como fatores preditivos do risco de metástases linfonodais e sua relação com a infecção pelo HPV em pacientes portadoras de carcinoma epidermóide de vulva. [Assessment of the value of immunohistochemical expression of e-cadherin and matrix metalloproteinases extracellular models 2 and 9 as risk factors predictive LNM and its relationship with infection HPV in patients with squamous cell carcinoma of vulva]. São Paulo, 2012. 83 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2012/FláviaCestari/FláviaCestari.pdf

Curriculum Lattes

NEOPLASIAS VULVARES; CARCINOMA EPIDERMOIDE; INFECCOES POR PAPILOMAVIRUS; MATRIZ EXTRACELULAR; IMUNOISTOQUIMICA; METASTASE NEOPLASICA


1371/2088US=84-A / Biol/Mol
Kohn EA, Tang B. Transformig growth factor-B in developing and advanced cancers: tumor suppresor and pro-progression roles for TGF-B in breast cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 285-307. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0.

TGF-B; CANCER DE MAMA; TUMOR SUPRESSOR; SUPRESSOR DE TUMOR; PROMOTOR DE TUMOR; PARACRINA


1372/2088US=90 / Biol/Mol
Buck E, Eyzaguirre A, Iwata KK. EGFR in tumorigenesis and EGFR tyrosine kinase inhibitors in cancer therapy: utilizing combination of molecular targeted agents to sensitize tumor cells to EGFR inhibitors. In: Haley JD, Gullick WJ. EGFR signaling networks in cancer therapy. New Jersey: Humana Press, 2008. p. 369-82. (Cancer Drug Discovery and Development) ISBN 978-1-59745-356-1.

EMT; TRANSICAO EPITELIAL MESENQUIMAL; ERLOTINIB; EGFR; IGF-1R; ER; HER3; MTOR; HDAC; SRC; COX-2


1373/2088US=98 / Biol/Mol
Nickoloff BJ. Tumor suppressing activities of senescent keratinocytes. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 195-207. ISBN 978-084939192-7.

TUMORAIS SUPRIMINDO; ATIVIDADES DE QUERATINOCITOS SENESCENTES


1374/2088US=98 / Biol/Mol
Roninson IB, Broude EV. Treatment-induced tumor cell senescence and its consequences. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 223-49. ISBN 978-084939192-7.

CELULAS TUMORAIS. TRATAMENTO SENESCENCIA; ANTICARCINOGENICO; SENESCENCIA CELULAR TUMORAL


1375/2088US=1 / Química
Harnett MM, Goodridge HS. Crescimento celular, diferenciação e câncer. In: Baynes JW, Dominiczak MH. Bioquímica médica. 2ª ed. Rio de Janeiro: Elsevier, 2007. p. 601-17. ISBN 85-3522298-2.

CICLO CELULAR; FATORES DE CRESCIMENTO CELULAR; RECEPTOR PDGF; RECEPTOR DE CITOCINA; REGULACAO DO CICLO CELULAR; APOPTOSE; CASPASE; CANCER; ONCOGENE; GENES SUPRESSORES DE TUMOR


1376/2088US=1 / Patologia
Kleihues P, Burger PC, Rosenblum MK, Paulus W, Scheithauere. Astrocytic tumours: anaplastic astrocytoma. In: Louis DN, Ohgaki H, Wistler OD, Cavenee WK, editors. WHO Classification of tumours of the central nervous system. 4th ed. Lyon: IARC, 2007. p. 30-2. (WHO Classification of Tumours, v. 1IARC WHO Classification of Tumours, nº 1) ISBN 978-92-832-2430-3.

TUMORES ASTROCITICOS; ASTROCITOMA ANAPLASICO; TUMOR GLIONEURONAL


1377/2088US=1 / Patologia
Daumas-Duport C, Pietsch T, Hawkins C, Shankar SK. Neuronal and mixed neuronal-glial tumours: dysembryoplastic neuroepithelial tumour. In: Louis DN, Ohgaki H, Wistler OD, Cavenee WK, editors. WHO Classification of tumours of the central nervous system. 4th ed. Lyon: IARC, 2007. p. 99-102. (WHO Classification of Tumours, v. 1IARC WHO Classification of Tumours, nº 1) ISBN 978-92-832-2430-3.

NEURONAL; TUMORES NEURONAL-GLIAL MISTOS; TUMOR NEUROEPITELIAL DISEMBRIOPLASICO


1378/2088US=1 / Patologia
Nakazato Y, Figarella-Branger D, Becker AJ, Scheithauer BW, Rosenblum MK. Neuronal and mixed neuronal-glial tumours: papillary glioneuronal tumour. In: Louis DN, Ohgaki H, Wistler OD, Cavenee WK, editors. WHO Classification of tumours of the central nervous system. 4th ed. Lyon: IARC, 2007. p. 113-4. (WHO Classification of Tumours, v. 1IARC WHO Classification of Tumours, nº 1) ISBN 978-92-832-2430-3.

PAPILAR TUMOR GLIONEURONAL; NEURONAL; TUMORES NEURONAL-GLIAL MISTOS


1379/2088US=1 / Patologia
Hainfellner JA, Scheithauer BW, Giangaspero F, Rosenblum MK. Neuronal and mixed neuronal-glial tumours: rosette-forming glioneuronal tumour of the fourth ventricle. In: Louis DN, Ohgaki H, Wistler OD, Cavenee WK, editors. WHO Classification of tumours of the central nervous system. 4th ed. Lyon: IARC, 2007. p. 115-6. (WHO Classification of Tumours, v. 1IARC WHO Classification of Tumours, nº 1) ISBN 978-92-832-2430-3.

TUMOR GLIONEURONAL; TUMOR FORMADOR DE ROSETAS DO QUARTO VENTRICULO; NEURONAL; TUMORES NEURONAL-GLIAL MISTOS


1380/2088US=1 / Patologia
Nakazato Y, Jouvet A, Scheithauer BW. Tumours of the pineal region: pineal parenchymal tumour of intermediate differentiation. In: Louis DN, Ohgaki H, Wistler OD, Cavenee WK, editors. WHO Classification of tumours of the central nervous system. 4th ed. Lyon: IARC, 2007. p. 124-5. (WHO Classification of Tumours, v. 1IARC WHO Classification of Tumours, nº 1) ISBN 978-92-832-2430-3.

TUMORES DA REGIAO PINEAL; TUMOR DO PARENQUIMA PINEAL


Primeira | Anterior | Próxima | Última